Boceprevir for previously treated chronic HCV genotype 1 infection (Q24620576)

6

0 references

Fred Poordad

7

object named as

Fred Poordad

0 references

Rafael Esteban

object named as

Rafael Esteban

14

0 references

Patrick Marcellin

4

object named as

Patrick Marcellin

0 references

TRAN Albert

1 reference

ORCID Public Data File 2021

author name string

Bruce R Bacon

1

0 references

Stuart C Gordon

2

0 references

Eric Lawitz

3

0 references

John M Vierling

5

0 references

Zachary D Goodman

8

0 references

Heather L Sings

9

0 references

Navdeep Boparai

10

0 references

Margaret Burroughs

11

0 references

Clifford A Brass

12

0 references

Janice K Albrecht

The New England Journal of Medicine

13

0 references

language of work or name

English

0 references

publication date

31 March 2011

0 references

published in

0 references

volume

364

0 references

page(s)

1207-17

0 references

issue

13

0 references

cites work

Evaluation of the TRUGENE HCV 5'NC Genotyping Kit with the New GeneLibrarian Module 3.1.2 for Genotyping of Hepatitis C Virus from Clinical Specimens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153125

Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153125

Boceprevir for untreated chronic HCV genotype 1 infection

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153125

Mechanism of action of interferon and ribavirin in treatment of hepatitis C

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153125

Telaprevir for previously treated chronic HCV infection

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153125

Adverse effects of drugs in the treatment of viral hepatitis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153125

Boceprevir, an NS3 protease inhibitor of HCV.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153125

Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153125

Boceprevir, an NS3 serine protease inhibitor of hepatitis C virus, for the treatment of HCV infection

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153125

Ribavirin mode of action in chronic hepatitis C: from clinical use back to molecular mechanisms

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153125

Peginterferon and ribavirin for chronic hepatitis C.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153125

Peginterferon alfa-2b and ribavirin for the treatment of chronic hepatitis C in blacks and non-Hispanic whites

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153125

Heterogeneous virologic response rates to interferon-based therapy in patients with chronic hepatitis C: who responds less well?

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153125

Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153125

Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153125

Peginterferon alfa-2b and weight-based or flat-dose ribavirin in chronic hepatitis C patients: a randomized trial

28 November 2018

1 reference